Actuate Therapeutics Inc
ACTU | NASDAQ
$0.93
+$0.02 (+2.50%)
Sep 22, 2026, 9:30 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 |
|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a |
Operating Income | -22.5M | -25.16M | -24.97M | -20.21M |
Interest Income | 287.71K | 222.29K | 352.67K | 27.03K |
Pretax Income | -22.23M | -27.28M | -24.74M | -20.16M |
Net Income | -22.23M | -27.29M | -24.74M | -20.16M |
Selling & General & Admin | 12.2M | 6.48M | 3.27M | 3.82M |
Research & Development | 10.29M | 18.68M | 21.71M | 16.39M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 22.5M | 25.16M | 24.97M | 20.21M |
Interest Expense | 20.25K | -18.72K | 43.64K | 16.2K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.49M | 25.16M | 24.97M | 20.21M |
Income Tax Expense | n/a | 800 | n/a | n/a |
Shares Outstanding (Basic) | 21.02M | 19.51M | 15.03M | 15.03M |
Shares Outstanding (Diluted) | 21.02M | 19.51M | 15.03M | 15.03M |
EPS (Basic) | -1.06 | -3.26 | -1.65 | -1.34 |
EPS (Diluted) | -1.06 | -3.26 | -1.65 | -1.34 |
EBITDA | -22.21M | -25.16M | -24.43M | -20.08M |
EBIT | -22.21M | -27.3M | -24.7M | -20.14M |
Depreciation & Amortization | n/a | 2.14M | 272.85K | 63.61K |
Add to Watchlist
Select watchlists to add or remove ACTU